- Home
- Labeler Index
- Braeburn Inc.
- 58284-264
- NDC Crossover: 58284-264 Brixadi
NDC Crossover 58284-264 Brixadi
View and Compare Similar Products, Alternatives & Options
NDC Crossover of Similar Products Matching Buprenorphine
The Similar Products in this help users find alternative medications and related products based on key similarities in their regulatory status, product name, active ingredients, dosage form, and administration route.
Explore similar products to 58284-264 – Brixadi, a human prescription drug. This list includes other cross-matching products that share:
- The same product name: Brixadi
- OR Generic name: Buprenorphine
- AND the same Administration Route: subcutaneous
- OR Dosage Form: injection
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Product Type |
---|---|---|---|---|---|---|
58284-208 | Brixadi | Buprenorphine | Injection | Subcutaneous | Braeburn Inc. | Human Prescription Drug |
58284-216 | Brixadi | Buprenorphine | Injection | Subcutaneous | Braeburn Inc. | Human Prescription Drug |
58284-224 | Brixadi | Buprenorphine | Injection | Subcutaneous | Braeburn Inc. | Human Prescription Drug |
58284-228 | Brixadi | Buprenorphine | Injection | Subcutaneous | Braeburn Inc. | Human Prescription Drug |
58284-232 | Brixadi | Buprenorphine | Injection | Subcutaneous | Braeburn Inc. | Human Prescription Drug |
58284-296 | Brixadi | Buprenorphine | Injection | Subcutaneous | Braeburn Inc. | Human Prescription Drug |